4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-25-049513
Co-Chief Executive Officer sold 21,490 shares at $3.47 ($74,482)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cohen Joshua B Co-Chief Executive Officer | 2025-03-31 | Sale | −21,490 | $3.47 | $74,482 | 3,355,280 | D |
| Open-market sales · 21,490 sh · avg $3.47 · $74,482 | |||||||
Loading xslF345X05/ownership.xml…